for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Miraca Holdings Inc.

4544.T

Latest Trade

2,543.00JPY

Change

-1.00(-0.04%)

Volume

480,100

Today's Range

2,501.00

 - 

2,550.00

52 Week Range

2,005.00

 - 

3,145.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
2,544.00
Open
2,544.00
Volume
480,100
3M AVG Volume
15.32
Today's High
2,550.00
Today's Low
2,501.00
52 Week High
3,145.00
52 Week Low
2,005.00
Shares Out (MIL)
56.98
Market Cap (MIL)
145,937.30
Forward P/E
29.55
Dividend (Yield %)
5.11

Next Event

H.U. Group Holdings Inc Annual Shareholders Meeting

Latest Developments

More

Miraca Holdings To Buy All Shares Of Tokyo-Based Selmesta

R&I affirms Miraca Holdings's rating at "A" and says stable outlook

Fujirebio Says Entered Into Agreement With Janssen Pharmaceuticals

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Miraca Holdings Inc.

H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.

Industry

Healthcare Facilities

Contact Info

Shinjuku Mitsui Bldg.

2-1-1, Nishishinjuku

SHINJUKU-KU, TKY

163-0408

Japan

+81.3.59093335

https://www.hugp.com/

Executive Leadership

Shigekazu Takeuchi

Representative Executive Officer, President, Group Chief Executive Officer, Director

Naoki Kitamura

Chief Financial Officer, Executive Officer, Chairman & Chief Executive Officer of Subsidiaries, Director

Yoshihiro Ashihara

Executive Officer, President of Subsidiary

Tadashi Hasegawa

Executive Officer, Chief Director of Planning Administration

Shunichi Higashi

Executive Officer, President of Subsidiary

Key Stats

3.00 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2018

0.2K

2019

0.2K

2020

0.2K

2021(E)

0.2K
EPS (JPY)

2018

4.510

2019

111.939

2020

-9.057

2021(E)

86.046
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.77
Price To Book (MRQ)
1.40
Price To Cash Flow (TTM)
13.50
Total Debt To Equity (MRQ)
69.29
LT Debt To Equity (MRQ)
54.14
Return on Investment (TTM)
-0.33
Return on Equity (TTM)
-0.25

Latest News

Latest News

Hitachi, Toshiba, Miraca to set up factory for coronavirus antigen tests

Japanese industrial conglomerates Hitachi Ltd and Toshiba Corp will join with Miraca Holdings to increase production of antigen-based coronavirus tests, aiding in the country's effort to screen more people for the new virus.

Hitachi, Toshiba, Miraca to set up plant for antigen test kits

Japanese industrial conglomerates Hitachi Ltd and Toshiba Corp, and Miraca Holdings subsidiary Fujirebio will jointly set up a plant in northern Japan to produce antigen coronavirus testing kits, the three companies said on Friday.

Miraca Holdings unit seeks approval for coronavirus antigen testing kits - govt

Japan's Miraca Holdings subsidiary Fujirebio on Monday applied for government approval for the nation's first antigen coronavirus testing kits, a health ministry official said.

BRIEF-Morpho says capital alliance with Miraca Holdings

* Says it plans to issue 100,800 shares of its common stock to Miraca Holdings Inc to raise 499.7 million yen via capital alliance, with payment date of Dec. 7

BRIEF- Miraca Holdings to offer early-retirement program

* Says the employees who take up the offer will retire on Jan. 31, 2018

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up